The production of membranous vesicles is observed to occur among organisms from all domains of the tree of life spanning prokaryotes (bacteria, archaea) and eukaryotes (plants, animals and fungi). Bacterial release of membrane-derived vesicles (MVs) has been studied most extensively in cases of Gram-negative species and implicating their outer membrane in formation of extracellular MVs. However, recent studies focusing on Gram-positive bacteria have established that they also undergo MV formation. Membrane vesicles are released during normal bacterial growth, they are derived from the bacterial membrane(s) and may function as transporters of different proteins, DNA and RNA to the neighbouring bacteria or to the cells of a mammalian host. The transport of virulence factors in a condensed manner via MVs to the host cells presumably protects these proteins from degradation and, thereby, targets the host cells in a specific manner. The aim of my thesis is to investigate secretion of MV-associated virulence factors and to study interactions of MVs produced by two selected Gram-negative and Gram-positive bacteria, i.e. Vibrio cholerae and Listeria monocytogenes, with eukaryotic host cells. Depending on whether the bacterium acts as an extracellular or intracellular pathogen, MVs may be considered to have specific functions, which may lead to the different outcomes of MV-host interactions. V. cholerae transport systems for virulence factors include the Type VI secretion system and MVs (also referred to as the “Type 0” secretion system). We have identified that the biologically active form of PrtV protease in different V. cholerae serogroups is transported via MVs. PrtV protease is essential for V. cholerae environmental survival and protection from natural predator grazing. We demonstrated that PrtV is primarily translocated via the inner membrane to the periplasmic space, where it undergoes autoproteolysis, and the truncated version of PrtV protein is packaged inside the MVs and released from the surface of bacteria. MV-associated PrtV protease showed a contribution to bacterial resistance towards the antimicrobial peptide LL-37, thereby, enhancing bacterial survival by avoiding this innate immune defense of the host. We also studied another virulence factor of V. cholerae, the pore-forming toxin VCC, which was found to be transported by MVs. MV-associated VCC is biologically active and triggers an autophagic response in the target cells. We suggested that autophagy serves as a cellular defense mechanism against the MV-associated bacterial virulence factor of V. cholerae. Listeria monocytogenes is a Gram-positive intracellular and facultative anaerobic food-borne pathogen causing listeriosis. It causes only sporadic outbreaks in healthy individuals, however, it is dangerous for a fetus or newborn child, and for pregnant and immunocompromised people, leading to a deadly infection in one third of the cases. We have analyzed MVs produced by L. monocytogenes and their interaction with eukaryotic cells. Confocal microscopy analysis showed that MVs are internalized into HeLa and HEK293 cells and are accumulated in lysosomes. Moreover, L. monocytogenes produces MVs inside the host cells and even inside the phagosomes. We found that the major virulence factor of L. monocytogenes, the cholesterol-dependent pore-forming protein listeriolysin O (LLO), is entrapped inside the MVs and resides there in an oxidized inactive state. LLO is known to induce autophagy by making pores in the phagosomal membrane of targeted eukaryotic cells. In our studies, we have shown that MVs effectively abrogated autophagy induced by Torin1, by purified LLO or by another pore-forming toxin from V. cholerae. We also found that MVs promote bacterial intracellular survival inside mouse embryonic fibroblasts. In addition, MVs have been shown to have a strong protective activity against host cell necrosis initiated by pore-forming toxin. Taken together, these findings suggested that in vivo MVs production from L. monocytogenes might be a relevant strategy of bacteria to manipulate host responses and to promote bacterial survival inside the host cells.

Pseudomonas aeruginosa is a Gram-negative rod, aerobic, non-fermenting, oxidase positive, pigment producing, and nutritionally versatile bacterium. Infections by P. aeruginosa are the most important cause of morbidity and mortality in immunocompromised patients, given virulence factor production that suppresses antibiotic therapy and promotes persistent infection. This research is the first comprehensive report of the pyrimidine biosynthetic pathway for all phases of growth in minimal and rich media coupled with the evaluation of virulence factor production of P. aeruginosa in comparison to four other bacterial species (Pseudomonas putida, Pseudomonas fluorescens, Burkholderia cepacia, and Escherichia coli wild-type strains). Cellular growth and passing genetic information to the next generation depend on the synthesis of purines and pyrimidines, the precursors of DNA and RNA. The pyrimidine biosynthetic pathway is essential and found in most organisms, with the exception of a few parasites that depend upon the pyrimidine salvage pathway for growth. Both the pyrimidine biosynthetic and salvage enzymes are targets for chemotherapeutic agents. In our laboratory, research on pyrimidine auxotrophic mutants showed the role of the pyrimidine biosynthetic pathway and its intermediates on P. aeruginosa metabolism and impaired virulence factors production. The present research shows that pyrimidine enzymes are active in all phases of growth, including the production of two forms of ATCase in the late log phase in P. aeruginosa. This finding may be explained by the displacement of the inactive PyrC' by the active PyrC or PyrC2 to form a new and larger pyrBC encoded ATCase. Pseudomonas aeruginosa wild-type appears to produce by far the most virulence factors, haemolysin, iron chelation, rhamnolipid, adherence, and three types of motility (swimming, swarming, and twitching) investigated in this study, when compared to the other four wild-type strains. Growth analysis was carried out as typically done in minimal medium but also in rich medium to simulate conditions in the blood and lung tissues of humans as P. aeruginosa infections develop.

L. pneumophila, der Erreger der Legionärskrankheit, kodiert für eine Vielzahl lipolytischer Enzyme. Bis zu 17 verschiedenen Proteinen kann aufgrund von Sequenzhomologien oder experimenteller Analyse phospholipolytische Eigenschaft zugeschrieben werden. Neben sekretierten Formen wird eine besonders aktive zell-assoziierte Variante exprimiert, die Phospholipase A/Lysophospholipase A PlaB. Wie bereits gezeigt werden konnte, kodiert das plaB Gen für die hauptsächliche membranständige Phospholipase A von L. pneumophila mit Enzymaktivitäten, die die Aktivität sekretierter Proteine um das 100-fache übersteigen. Da PlaB zu keiner der bisher beschriebenen Phospholipasen Homologien aufweist, wurden in dieser Arbeit durch gezielte Mutagenese die katalytisch wichtigen Aminosäuren identifiziert. Dies ergab, dass PlaB zwar eine für Lipasen und Proteasen typische katalytische Triade aus Serin, Asparat und Histidin ausbildet, die umliegenden Motive sich aber deutlich von bisher beschriebenen Enzymklassen unterscheiden. Somit stellt PlaB das erste näher charakterisierte Mitglied einer neuen Familie phospholipolytischer Enzyme dar. Im Weiteren konnten für die Substratspezifität wichtige Aminosäurereste identifiziert werden. Dabei stellte sich heraus, dass die Fähigkeit zur Hydrolyse von cholinkettentragenden Substraten besonders suszeptibel gegenüber Mutationen war. Da im Vergleich zu nicht-pneumophila Stämmen, wie z. B. L. spiritensis, nur L. pneumophila in der Lage war, diese Lipide in hohem Maße umzusetzen, kann die Eigenschaft von PlaB, Phosphatidylcholin (PC) zu hydrolysieren, einen Virulenzvorteil für L. pneumophila bedeuten. Die Hypothese konnte durch Hämolyse-experimente bestärkt werden. Hier zeigten sich Mutanten mit reduziertem Potential zur Hydrolyse von PC weniger zytotoxisch gegenüber humanen Erythrozyten. Das zell-zerstörende Potential von PlaB könnte somit eine enorme Auswirkung auf die Virulenzeigenschaften von L. pneumophila haben. Wie in der vorliegenden Arbeit untersucht, bestätigten in vitro Experimente, dass PlaB die hauptsächliche Aktivität während einer Makrophageninfektion darstellt, die Deletion des Gens aber keine Auswirkungen auf das Replikationspotential der Bakterien hat. Ganz im Gegenteil dazu waren plaB Insertionsmutanten bei der Infektion von Meerschweinchen in ihrer Vermehrungsfähigkeit in der Lunge als auch in der Verbreitung der Erreger zur Milz der Tiere reduziert. Um den Grund des Defektes näher zu erörtern, wurde in einem Screen auf 40 verschiedene Entzündungsmediatoren die Sekretion von IL-8, MCP-1, RANTES und TIMP-2 als PlaB-abhängig identifiziert. Somit repräsentiert die zell-assoziierte Phospholipase A, PlaB, von L. pneumophila eine neue Klasse lipolytischer Enzyme und kann durch Hydrolyse eines breiten Substratspektrums, insbesondere durch Hydrolyse von PC, die Vermehrung und Verbreitung des Erregers im Wirtsorganismus unterstützen. / L. pneumophila, the causative agent of Legionnaires’ disease (LD) expresses numerous lipolytic enzymes. According to sequence homology or determined lipolytic activities, up to 17 open reading frames of the L. pneumophila genome may encode functional phospholipases. In addition to secreted and/or injected lipolytic enzymes, it was shown that the pathogen expresses a highly active and membrane-bound phospholipase A/lysophospholipase A with hemolytic activity, designated PlaB. As PlaB does not belong to any established bacterial or eukaryotic protein family of lipolytic enzymes nor does it show sequence homology to conserved motifs harboring the catalytically important amino acids, we analyzed putative catalytic centers using site-directed mutagenesis. This study shows that PlaB exhibits a catalytic triad of serine, aspartate and histidine residues, most commonly found within lipolytic and proteolytic enzyme families. However, surrounding motifs differ significantly from described ones. Thus, PlaB is the first representative of a new class of lipolytic enzymes. In addition, we described amino acids important for substrate specificity, revealing that the ability to hydrolyze phosphatidylcholine (PC) is severely susceptible to various mutations. Since PlaB of non-pneumophila strains, such as L. spiritensis, express comparable activities against glycerol-containing lipids, but are reduced in their hydrolytic potential to cleave choline-containing substrates, PC-targeting activity could be an important contribution to the pathogenicity of L. pneumophila, the most common cause of LD. The hypothesis was underlined by reduced hemolytic potential of L. spiritensis PlaB and PC-hydrolysis impaired mutants of L. pneumophila PlaB and is in accordance with PC being the major lipid in the outer leaflet of eukaryotic membranes. The cell destructive properties of PlaB may enhance bacterial pathogenicity in multiple ways. As depicted within this study, PlaB represents the major lipolytic activity present throughout host cell infections; however, gene deletion mutants retained their ability to multiply within several host cell infection systems. On the contrary, the plaB mutant strain was inhibited in replicating in the lung and disseminating to other organs in a guinea pig infection model. To elucidate the impact of PlaB on Legionella virulence we investigated 40 inflammatory factors secreted by lung epithelial cells upon Legionella infection and observed that IL-8, MCP-1, RANTES and TIMP-2 are released in a PlaB-dependent manner. Thus, PlaB represents a new family of lipolytic enzymes which could, according to the lipolytic profile and especially the ability to hydrolyse PC, contribute to replication and dissemination properties of a pathogen within a host cell, e.g. amoeba, or even more complex organisms such as guinea pigs or humans.

Nach der Eradikation der humanen Pockenerkrankung stellen zoonotische Orthopockenvirus-(OPV-)Infektionen heute eine mögliche Bedrohung der öffentlichen Gesundheit dar. Hierbei sind insbesondere Kuhpocken-(CPXV), Affenpocken-(MPXV) und Vaccinia Viren (VACV) von Bedeutung. In dieser Arbeit wurde das Genexpressionsprofil humaner (HeLa) Zellen nach Infektion mit CPXV, MPXV oder VACV untersucht. Es wurden sowohl zelluläre Gene identifiziert, welche generell von allen verwendeten Viren reguliert wurden, als auch Gene, die eine Virus-spezifische Regulation durch individuelle OPV aufwiesen. Gemeinsamkeiten zeigten sich insbesondere zwischen CPXV und MPXV, welche, im Gegensatz zu VACV, die Expression zahlreicher Cytokine und Chemokine induzierten. Insbesondere für Interleukin-6, -8 und CXCL1 konnte auch auf Proteinebene eine gesteigerte Sekretion durch CPXV-infizierte Zellen nachgewiesen werden. Vermutlich aufgrund dieser Induktion, trat in vitro eine verstärkte Rekrutierung von Monozyten und Makrophagen in Folge einer CPXV-, nicht aber einer VACV-Infektion auf. Makrophagen spielen eine kontroverse Rolle im Rahmen einer OPV-Infektion und sind sowohl für deren Bekämpfung, als auch, im infizierten Zustand, für die Ausbreitung der Viren im Organismus von Bedeutung. Daher wurde die Replikationsfähigkeit von CPXV und VACV in Makrophagen charakterisiert. Der Virulenzfaktor p28, welcher von den meisten VACV Stämmen nicht kodiert wird, konnte als essentiell für die Replikation von CPXV in einer murinen Makrophagen-Zelllinie, primären peritonealen Makrophagen der Ratte und in Makrophagen aus primären humanen PBMCs identifiziert werden. In Anbetracht der Bedeutung der Replikationsfähigkeit in Makrophagen für die Ausbreitung einer OPV-Infektion im Wirtsorganismus, deuten diese Ergebnisse darauf hin, dass CPXV, im Fall einer weiteren Adaption an den Menschen, ein höheres Bedrohungspotential im Vergleich zu VACV aufweisen könnten. / Today, following the eradication of human smallpox, zoonotic infections caused by orthopoxviruses (OPV) are emerging as a potential human health threat. Especially cowpox viruses (CPXV), vaccinia viruses (VACV), and monkeypox viruses (MPXV) are gaining importance as a cause of infectious disease of man and livestock. This study aimed to analyse and compare the gene expression profile of human (HeLa) cells following infection with CPXV, MPXV or VACV. Cellular genes were identified which were either commonly modulated by infection with any of the three viruses, or which were specifically modulated by one individual OPV. Particularly similar effects on cellular gene expression were observed in the case of CPXV and MPXV infection, which both induced the expression of several cytokine and chemokine genes. Especially interleukin-6, -8, and CXCL1 were strongly secreted by CPXV-infected cells but not by VACV-infected cells. Consequently, CPXV infection also induced a strong chemotactic recruitment of monocytes and macrophages in vitro in contrast to VACV infection. Especially macrophages are known to play a controversial role during OPV infection. On the one hand, macrophages are of importance for the control of the infection. On the other hand, infected macrophages also facilitate virus spread across the organism. Therefore, the capability of CPXV and VACV to replicate in macrophages was analysed. Thereby, the poxviral virulence factor p28, which is absent from most strains of VACV, was identified as an essential factor, allowing CPXV replication in a murine macrophage cell line, primary peritoneal rat macrophages and in human PBMC-derived macrophages. Concerning the importance of productively infected macrophages for OPV spread, these results suggest that CPXV, if further adapted to human beings as host species, may harbor a greater threat to human health when compared to VACV.

La trypanosomose est la maladie parasitaire la plus dévastatrice en Afrique, et affecte à la fois les hommes et le bétail. Vu l’inefficacité des stratégies de contrôle actuelles, une stratégie alternative dite “anti-maladie” a été proposée dans le cadre de la trypanosomose animale. Elle vise à neutraliser les effets de la maladie plutôt qu’à éliminer le parasite. Une telle stratégie nécessite une meilleure compréhension du développement de la pathologie ainsi qu’une caractérisation détaillée des facteurs de virulence impliqués. Dans ce contexte, nous nous sommes intéressés à l’étude de l’interaction hôte/pathogène entre les trypanosomes Africains et l’endothélium de l’hôte mammifère. En comparant quatre espèces différentes de trypanosomes Africains, nous avons montré que leurs capacités d’activation des cellules endothéliales étaient distinctes. Nous avons clairement démontré que T. congolense, T. vivax et T. b. gambiense activent les cellules endothéliales via la voie de NF-ƘB, alors que T. b. brucei est incapable d’activer cette voie. Cette activation a induit une résponse pro-inflammatoire in vitro et in vivo, ce qui souligne l’importance de ce mécanisme dans le développement de la maladie. Pour la première fois, nous avons identifié une activité sialidase chez le parasite de l’homme T. brucei gambiense, et nous avons démontré que les trans-sialidases trypanosomales sont les médiateurs de cette activation endothéliale et de la réponse inflammatoire consécutive, et ceci à la fois chez les trypanosomes africains d’homme et d’animaux. De plus, nous avons montré que l’activation endothéliale implique l’activité lectin-like des trans-sialidases et non pas l’activité catalytique, ainsi que des récepteurs sialylés sur la surface endothéliale. En conclusion, ce travail a apporté des avancées considérables dans la compréhension de la relation hôte/pathogène et a permis de désigner les sialidases comme un facteur de virulence central dans le dialogue intermoléculaire durant les trypanosomoses, en faisant une cible de choix pour le vaccin « anti-maladie ». / Trypanosomiasis remains by far the most devastating parasitic disease in Africa affecting both humans and livestock. The current control strategies being not efficient, an alternative “anti-disease” strategy aiming to neutralize the pathological effects of the parasite rather than to eliminate it, was proposed. Therefore, it is essential to understand the development of pathogenesis and characterize the involved pathogenic factors. In this context, we wanted to elucidate the host-pathogen interaction between the African trypanosomes and the mammalian host endothelium. By comparing four different trypanosomes species, we showed that they displayed distinct capacities for activation of endothelial cells. We clearly demonstrated that T. congolense, T. vivax and T. b. gambiense activate the endothelial cells via the NF-ƘB pathway, but not T. b. brucei. This activation caused a pro-inflammatory response in vitro and in vivo, showing the importance of this mechanism in the development of pathogenesis. For the first time, we identified sialidase activity in the human parasite T. brucei gambiense, and demonstrated that the trypanosomal trans-sialidases are the mediators of this endothelial activation and its consequent inflammatory response, for both human and animal trypanosomes. Additionnally, we showed that endothelial cell activation is mediated by the lectin-like domain of the trans-sialidase rather than the catalytic site, and involves sialylated receptors of the endothelial cell surface. In conclusion, our study brings considerable insights into the host-pathogen relationship and designates sialidases as a central virulence factor in the molecular crosstalk during trypanosomiasis, which makes it a perfect target for the anti-disease strategy.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Orf virus (ORFV) belongs to the family Poxviridae, subfamily Chordopoxvirinae and genus Parapoxvirus and is the agent of contagious ecthyma, a mucocutaneous disease that affects mainly young sheep and goats and, occasionally, may affect people. The clinical lesions progress through stages of hyperemia, papules, vesicles, pustules, ulcers and proliferative and scabby lesions, located mainly on the labial commissure, lips and nostrils. Variable clinical lesions with different degrees of severity often occur in sheep and goats, and may be associated with host and/or viral genetics. The present study aimed to investigate the phenotype in vivo and to characterize virulence genes of four ORFV isolates recovered from contagious ecthyma outbreaks in Rio Grande do Sul State, Brazil. Twenty sheep, aged 6 and 8 months, were divided into five groups of four animals each and inoculated in the labial commissure with homogenates of scabs (viral titers 105.6TCID50/ml) obtained from different outbreaks: SV269/11, SV252/11, SV581/11 and SV820/10-Canguçu. The animals were evaluated for 30 days in clinical and virological aspects by clinical inspection and swab collection for virus isolation. A clinical score was established for each animal and group. All ORFV inoculated animals developed classical ecthyma contagious lesions, characterized by hyperemia, papules, macules, vesicles, pustules and scabs in varied degrees and duration. SV269/10 and SV820/10-Canguçu isolates induced more severe lesions resulting in higher clinical scores and longer duration of lesions. The animals inoculated with SV581/11 developed milder lesions and clinical scores significantly lower than other groups, but they shed virus for a longer period of time. For genetic analyses, PCR amplification and nucleotide sequencing of three virulence genes (VEGF, VIR and IL-10v) were performed. Deletion and mutations on VEGF and IL-10v amino acid sequence of SV581/11 and SV252/11 isolates were identified. The degree of amino acid identity among ORFV sequences was variable, and the lowest homology was found in the VEGF gene of SV581/11 when compared with the standard strains and other viruses. Thus, the present results showed that SV581/11 and SV252/11 isolates, particularly the former, are less virulent in sheep than SV269/11 and SV820/10-Canguçu. Possibly, the variable phenotypic observed in vivo is due to genetic alterations detected in the analyzed virulence genes. / O vírus da orf (ORFV) pertence à família Poxviridae, subfamília Chordopoxvirinae gênero Parapoxvirus e é o agente etiológico do ectima contagioso, uma doença mucocutânea que afeta principalmente ovinos e caprinos jovens e pode, ocasionalmente, afetar pessoas. Clinicamente, a enfermidade evolui com a formação de áreas hiperêmicas, vesículas, pústulas, úlceras e lesões proliferativas e crostosas sobre a pele dos lábios, comissura labial e narinas. Apresentações clínicas variáveis, com diferentes graus de severidade, ocorrem frequentemente e podem estar associadas a características do hospedeiro e, principalmente, a características genéticas do agente. O presente trabalho teve como objetivo investigar o fenótipo in vivo e caracterizar genes de virulência de quatro amostras de ORFV oriundas de surtos no Estado do Rio Grande do Sul, Brasil. Para isso, foram utilizados vinte ovinos, com idade entre 6 e 8 meses, divididos em cinco grupos de quatro animais cada. Os ovinos foram inoculados na comissura labial com homogeneizados de crostas (títulos virais 105,6 DICC50/ml) obtidas dos surtos (amostras SV269/11, SV252/11, SV581/11 e SV820/10-Canguçu). Os animais foram avaliados durante 30 dias com relação aos aspectos clínicos e virológicos, por inspeção clínica e coleta de suabes das lesões para detecção da excreção viral. As manifestações clínicas foram convertidas em um escore clínico, para cada animal e para os grupos. Os animais inoculados com os as quatro amostras desenvolveram lesões típicas de ectima contagioso, caracterizadas por hiperemia, pápulas, máculas, vesículas e pústulas, e formação de crostas em diferentes graus de intensidade e duração. As amostras SV269/10 e SV820/10-Canguçu induziram lesões mais graves, escores clínicos maiores e maior tempo de duração das lesões. Os animais inoculados com a amostra SV581/11 desenvolveram lesões e escores clínicos significativamente inferiores aos demais grupos, mas excretaram o vírus por período mais longo. Para a caracterização genética, foi realizada a amplificação por PCR e sequenciamento de nucleotídeos de três genes de virulência (VEGF, VIR e IL-10v). Foram identificadas deleções e mutações nas sequências dos genes VEGF e IL-10v das amostras SV581/11 e SV252/11. O grau de identidade de aminoácidos entre as amostras foi variável, sendo que a menor homologia foi encontrada no gene VEGF da amostra SV581/11, quando comparado com os demais vírus e a cepa padrão. Assim, os resultados obtidos demonstram que as amostras SV581/11 e SV252/11, em especial a primeira, foram menos virulentas em ovinos do que as amostras SV269/11 e SV820/10-Canguçu. Possivelmente essa diferença fenotípica observada in vivo seja resultado das alterações genéticas detectadas nos genes de virulência.

Das Typ III Sekretionssystem (T3SS) ist ein Proteinkomplex den Gramnegative Bakterien nutzen um in einem Schritt Effektorproteine (Effektoren) aus dem Zytosol über die Doppelmembran zu sekretieren. Für viele Bakterien ist das T3SS ein essenzieller Virulenzfaktor, der es ihnen erlaubt mit ihrem Wirt zu interagieren und diesen zu manipulieren. Charakteristisch für das T3SS ist die strukturelle Komponente, der Nadelkomplex. Dieser ähnelt strukturell einer Spritze, deren Basalkörper die bakteriellen Membranen und das Periplasma durchspannt und einer Nadel, die vom Basalkörper aus dem Bakterium ragt. Basierend auf dem Modell einer Spritze wird angenommen, dass Effektoren entfaltet und anschließend durch Basalkörper und Nadelkanal sekretiert werden. Trotz der kontinuierlichen Forschung an T3SS entbehrt dieses Modell einer experimentellen Grundlage und der Mechanismus ist nicht vollständig erklärt. Ziel der Arbeit war es, eine experimentelle Basis für den Sekretionsmechanismus des T3SS zu schaffen. Um zu verstehen, wie das T3SS Effektoren sekretiert, wurden zunächst Fusionsproteine konstruiert, welche aus einem Effektor und einem stabil gefalteten Knotenprotein bestehen. Aufgrund des Knotens in der Fusion ist davon auszugehen, dass dieser während der Sekretion nicht entfalten kann. Die Effektordomäne wird sekretiert während der Knoten im Kanal verbleibt und diesen verstopft. Nach unseremWissen ist diese Arbeit die erste Visualisierung von Effektorfusionen an isolierten Nadelkomplexen. Die Effektorfusion wird N-terminal voran durch den Kanal sekretiert, wobei der Kanal das Substrat umschließt und gegen Proteasen und chemische Modifikationen abschirmt. Die Ergebnisse dieser Arbeit untermauern eine Grundidee der Funktionsweise des T3SS und liefern eine vielversprechende Strategie für in situ-Strukturanalysen. Dieser Ansatz lässt sich auch auf andere Proteinsekretionssysteme übertragen, bei welchen Substrate vor dem Transport entfaltet werden müssen. / The Type III Secretion System (T3SS) is a complex used by Gram-negative bacteria to secrete effector proteins from the cytoplasm across the bacterial envelope in a single step. For many pathogens, the T3SS is an essential virulence factor that enables the bacteria to interact with and manipulate their respective host. A characteristic structural feature of the T3SS is the needle complex (NC). The NC resembles a syringe with a basal body spanning both bacterial membranes and a long needle-like structure that protrudes from the bacterium. Based on the paradigm of a syringe-like mechanism, it is generally assumed that effectors are unfolded and secreted from the bacterial cytoplasm through the basal body and needle channel. Despite extensive research on T3SS, this hypothesis lacks experimental evidence and the mechanism of secretion is not fully understood. This work aimed to provide an experimental basis for the model of the T3SS mechanism. In order to elucidate details of the effector secretion mechanism, fusion proteins consisting of an effector and a bulky protein containing a knotted motif were generated. It is assumed that the knot cannot be unfolded during secretion of the chimera. Consequently, these fusions are accepted as T3SS substrates but remain inside the NC channel and obstruct the T3SS. This is, to our best knowledge, the first time effector fusions have been visualized together with isolated NCs and it demonstrates that effector proteins are secreted directly through the channel with their N-terminus first. The channel encloses the substrate and shields it from a protease and chemical modifications. These results corroborate an elementary understanding of how the T3SS works and provide a powerful tool for in situ-structural investigations. This approach might also be applicable to other protein secretion systems that require unfolding of their substrates prior to secretion.

No description available.

No description available.